Genomic Analysis

Dell Technologies drives innovation with latest solutions for HPC and AI | 11/10/2020

… says. Enabling new discoveries with Dell EMC Ready Solutions for HPC Genomics According to Dell, the new Dell EMC Ready Solution for HPC Genomics is engineered and tested to help companies get systems for genomic analysis into production quickly and economically. Modular building blocks with Dell EMC PowerEdge servers, Dell EMC PowerSwitch networking and Dell EMC storage can be configured to meet different use cases. Specially-designed software for bioinformatics …

Dell Technologies HPC and AI Solutions Help TGen Reduce Genome Sequencing Time from Two Weeks to Less Than Eight Hours | State News | moorenews.com | 11/9/2020

… who will shape our future.” Dell EMC Ready Solutions for HPC Genomics aid new discoveries The new Dell EMC Ready Solution for HPC Genomics is engineered and tested to help companies get systems for genomic analysis into production quickly and economically. Modular building blocks with Dell EMC PowerEdge servers, Dell EMC PowerSwitch networking and Dell EMC storage can be configured to meet different use cases. Specially-designed software for bioinformatics …

Follow Genomic Analysis:    

Congenica Completes $50m Series C Funding Round to - One News Page | 11/9/2020

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations Cambridge, United Kingdom ‚Äì 9 November 2020 - Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people‚Äôs lives, is pleased to announce the completion of its …

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform | 11/9/2020

Report from cyberbullying expert identifies ‚Äònegligence‚Äô towards student‚Äôs wellbeing at Institut Le Rosey First Passengers Travel Safely on a Hyperloop with Pune Local to Ride Next Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform Congenica Completes $50m Series C Funding Round to Advance Clinical …

Vaquita Genome Offers Hope for Species’ Survival | 11/9/2020

… Now, an international team of researchers, in collaboration with the Vertebrate Genomes Project , has used her living cells to generate the most complete high-quality genome sequence of any dolphin, porpoise or whale. The genomic analysis , published in Molecular Ecology Resources in October, reignites hope for the fast-disappearing species. It confirms that the small remaining population is genetically healthy and can still recover if authorities enforce existing conservation measures …

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform | 11/9/2020

November 9, 2020 Asean , PRESS RELEASES Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations Cambridge, United Kingdom ‚Äì 9 November 2020 ‚Äì Congenica , the digital health company enabling rapid and accurate analysis of complex genomic data to transform people‚Äôs lives, is …

Investigation of Two Mycobacterium abscessus Outbreaks in Quebec Using Whole Genome Sequencing | 11/9/2020

In recent decades, nontuberculous mycobacteria (NTM) infections are of emerging public health concern and have contributed towards significant clinical and economic burden globally. One such rapid growing mycobacteria, Mycobacterium abscessus , can cause clonal outbreaks, and these bacteria exhibit a highly resistant antimicrobial susceptibility profile. Here, we present an investigation of two small outbreaks of M. abscessus : first in a pediatric clinic setting and second in a tattoo parlour from Quebec …

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform | 11/9/2020

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform Posted by admin on in PRESS RELEASES 0 Views Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations Cambridge, United Kingdom ‚Äì 9 November 2020 ‚Äì Congenica …

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform | 11/9/2020

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations Cambridge, United Kingdom ‚Äì 9 November 2020 ‚Äì Congenica , the digital health company enabling rapid and accurate analysis of complex genomic data to transform people‚Äôs lives, is pleased to announce the completion of …

Congenica Completes $50 Million Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform | 11/9/2020

… Äù‚Äù custom-id=‚Äù‚Äù css=‚Äù.vc_custom_1523079266073(margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;)‚Äù] Congenica Completes $50 Million Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform On Nov 9, 2020 Share Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people‚Äôs lives, is pleased to announce the completion …

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform | 11/9/2020

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform On By admin-b Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations Cambridge, United Kingdom ‚Äì 9 November 2020 ‚Äì Congenica , the digital health company enabling …

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform | 11/9/2020

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations Cambridge, United Kingdom ‚Äì 9 November 2020 ‚Äì Congenica , the digital health company enabling rapid and accurate analysis of complex genomic data to transform people‚Äôs lives, is pleased to announce the completion of …

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform | 11/9/2020

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform 9, 2020 Press Releases Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations Cambridge, United Kingdom ‚Äì 9 November 2020 ‚Äì Congenica , the digital health company enabling …

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform | 11/9/2020

November 9, 2020 PRESS RELEASES Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations Cambridge, United Kingdom ‚Äì 9 November 2020 ‚Äì Congenica , the digital health company enabling rapid and accurate analysis of complex genomic data to transform people‚Äôs lives, is pleased …

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform | 11/9/2020

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform November 9, 2020 admin PRESS RELEASES Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations Cambridge, United Kingdom ‚Äì 9 November 2020 ‚Äì Congenica , the digital health …

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform | 11/9/2020

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform admin Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations Cambridge …

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform | 11/9/2020

… Parkwalk, Cambridge Innovation Capital and Downing also participated. The global nature of this important financing round brings new strategic and geographic capabilities that will further advance Congenica‚Äôs existing global footprint. A pioneer in genomic analysis, Congenica has established a diverse, global customer-base of hospitals, diagnostic laboratories, academic medical centres and pharmaceutical companies based on its exceptional scientific heritage from the Wellcome Sanger Institute and as the exclusive Clinical …

Denmark to kill all minks to stop spread of mutated coronavirus to humans | 11/8/2020

… Frederiksen made the decision public on November 4, 2020. He acknowledged that it was a ‚Äúheavy decision‚Äù but the situation required ‚Äúresolute action.‚Äù Denmark’s Health Minister Magnus Heunicke stated that as per genomic analysis , almost 400 human COVID-19 infection cases in northern Denmark were related to mink farms, which amounts to almost half of all cases. As per Denmark‚Äôs Statens Serum Institut, around 5 percent of …

Global Biotech Firm Macrogen Selects HPE GreenLake to Accelerate Genomic Analysis and DNA Sequencing | BioSpace | 11/3/2020

Macrogen has more than 18,000 customers in 153 countries and has the fifth-largest genetic analysis capability in the world. The company‚Äôs long-term mission is to build big data that improve prediction and prevention of human diseases and provide precision medicine. Genomic analysis and DNA sequencing are used in research and clinical trials where data cannot be stored in external facilities such as public clouds, due to privacy …

Genomic Prediction Technology Uncovers New CRISPR Safety Concerns in Human Embryos | PR Newswire | 11/2/2020

NORTH BRUNSWICK, N.J. In a new cutting-edge study, Genomic Prediction’s advanced genomic analysis techniques provide unprecedented detail into how genetic editing using CRISPR plays out in human embryos ‚Äì revealing unintended chromosomal deletions. The discovery, published in the journal Cell, reveals that attempts to edit a single gene can result in the elimination of whole or large parts of chromosomes in the embryo. CRISPR Can Cut Out Whole Chromosomes …

Bioenergy research team sequences miscanthus genome | Phys Org | 10/29/2020

… grow. It can thrive on marginal lands, requires only limited fertilization, has a high tolerance for drought and cool temperatures, and uses the more efficient C4 form of photosynthesis. The CABBI team’s sequence and genomic analysis of Miscanthus sinensis‚Äîthe first for any type of miscanthus‚Äîprovide a foundation for systematic improvements to optimize those desirable traits. The project also produced an atlas of genes that are turned on and …

Bioenergy research team sequences miscanthus genome | 10/29/2020

… grow. It can thrive on marginal lands, requires only limited fertilization, has a high tolerance for drought and cool temperatures, and uses the more efficient C4 form of photosynthesis. The CABBI team’s sequence and genomic analysis of Miscanthus sinensis – the first for any type of miscanthus – provide a foundation for systematic improvements to optimize those desirable traits. The project also produced an atlas of genes that are turned on and …

Bioenergy research team sequences miscanthus genome | 10/28/2020

… grow. It can thrive on marginal lands, requires only limited fertilization, has a high tolerance for drought and cool temperatures, and uses the more efficient C4 form of photosynthesis. The CABBI team’s sequence and genomic analysis of Miscanthus sinensis – the first for any type of miscanthus – provide a foundation for systematic improvements to optimize those desirable traits. The project also produced an atlas of genes that are turned on and …

Bioenergy research team sequences miscanthus genome | 10/28/2020

… grow. It can thrive on marginal lands, requires only limited fertilization, has a high tolerance for drought and cool temperatures, and uses the more efficient C4 form of photosynthesis. The CABBI team’s sequence and genomic analysis of Miscanthus sinensis – the first for any type of miscanthus – provide a foundation for systematic improvements to optimize those desirable traits. The project also produced an atlas of genes that are turned on and …

Superior outcomes for acute myeloid leukemia patients in clinical trial | 10/27/2020

… had superior outcomes compared to acute myeloid leukemia (AML) patients who opted for standard chemotherapy treatment, according to findings published today in Nature Medicine . The Beat AML trial achieved its primary endpoint by showing genomic analysis of the leukemia cells to identify AML subtypes can be completed within an unprecedented seven days, giving patients , caregivers and their doctors ample time to make a more personalized treatment decision without risking the …

Digital Health

Congenica Completes $50m Series C Funding Round to - One News Page | 11/9/2020

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations Cambridge, United Kingdom ‚Äì 9 November 2020 - Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people‚Äôs lives, is pleased to announce the completion of its …

Precision Medicine

Global Biotech Firm Macrogen Selects HPE GreenLake to Accelerate Genomic Analysis and DNA Sequencing | BioSpace | 11/3/2020

Macrogen has more than 18,000 customers in 153 countries and has the fifth-largest genetic analysis capability in the world. The company‚Äôs long-term mission is to build big data that improve prediction and prevention of human diseases and provide precision medicine. Genomic analysis and DNA sequencing are used in research and clinical trials where data cannot be stored in external facilities such as public clouds, due to privacy …

Biotech

Global Biotech Firm Macrogen Selects HPE GreenLake to Accelerate Genomic Analysis and DNA Sequencing | BioSpace | 11/3/2020

… long-term mission is to build big data that improve prediction and prevention of human diseases and provide precision medicine. Genomic analysis and DNA sequencing are used in research and clinical trials where data cannot … which need to be stored and analyzed every day. The biotech company consequently needed to develop cost-efficient, state-of-art genomic analysis systems to handle big data, while ensuring compliance with security policies to …

CRISPR

Genomic Prediction Technology Uncovers New CRISPR Safety Concerns in Human Embryos | PR Newswire | 11/2/2020

NORTH BRUNSWICK, N.J. In a new cutting-edge study, Genomic Prediction’s advanced genomic analysis techniques provide unprecedented detail into how genetic editing using CRISPR plays out in human embryos ‚Äì revealing unintended chromosomal deletions. The discovery, published in the journal Cell, reveals that attempts to edit a single gene can result in the elimination of whole or large parts of chromosomes in the embryo. CRISPR Can Cut Out Whole Chromosomes …

Genomics

Integrating large-scale Genomic Variation and Annotation Data with Glow | 10/9/2020

… known as “junk DNA”? And everything in between. Recently (since release 0.4), Glow , an open-source toolkit for large-scale genomic analysis, introduced the capability to ingest genomic annotation data from the GFF3 (Generic Feature … as well. import glow glow.register(spark) gff_path = ‘/databricks-datasets/genomics/gffs/GCF_ 1405.39_GRCh38.p13_genomic.gff.bgz’ annotations_df = spark.read.format(‘gff’).load(gff_path) \ .filter(“seqid = ‘NC_000022.11’”) \ .alias(‘annotations_df’) Figure 1: A small …

NIH

COVID research updates: Teenager spreads coronavirus on family holiday | Nature | 10/6/2020

… of coughing and shortness of breath. What the immune response to the coronavirus says about the prospects for a vaccine Genomic analysis by Jason Goldman at the University of Washington, Seattle, and his colleagues (J … coloured) isolated from a person with COVID-19. Credit: NIAID/NIH/SPL 22 September — Good timing might help the immune system to control COVID-19 People aged 65 and older who are infected with the …

Medicare

Opinion: A national registry could help defeat sepsis, a big contributor to Covid-19 deaths | STAT | 6/9/2020

… in a matter of weeks to months, but some experience permanent deficits. advertisement Additionally, based on a recent analysis of Medicare beneficiaries who survived sepsis, older survivors of Covid-19-related sepsis will face a … 75% in 1975. We now have the capability to perform genomic analysis on cancer cells and determine the most effective treatment individualized to the patient, minimizing unnecessary side effects. A sepsis registry will provide the …

Food and Drug Administration

FDA Grants Breakthrough Device Designation to DNAe’s Sequencing Diagnostic | Business Wire | 4/9/2020

LONDON & CARLSBAD, Calif.- DNAe, the next generation sequencing company developing novel diagnostics for use at the point-of-need, today announced that the US Food and Drug Administration (FDA) has granted it a “Breakthrough Device” designation for its pioneering platform and first assay. DNAe has reinvented sequencing in order to develop a compact device operable by non-specialist users. LiDia-SEQ™ will, for the first time, bring genomic analysis into …

CDC

DermTech Announces Response to COVID-19 | Business Wire | 3/25/2020

… an effort to limit the spread of COVID-19, we are managing our staffing and travel as guided by the CDC, OSHA, and state and local governments. We have implemented a work from home policy … leading to improved patient care and lower costs. DermTech provides genomic analysis of skin samples collected non-invasively using an adhesive patch rather than a scalpel. DermTech markets and develops products that facilitate the early …

National Institutes of Health

COVID-19 not man-made, comparative genomic study finds | Modern Healthcare | 3/18/2020

… man-made, comparative genomic study finds Modern Healthcare Print AP This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, orange … evolved from naturally occurring strains, according to a new comparative genomic analysis. “By comparing the available genome sequence data for known coronavirus strains, we can firmly determine that SARS-CoV-2 originated through natural processes …

RNA Sequencing

Genomic Testing Cooperative to Present Data on its Proprietary RNA Profiling and Artificial Intelligence Algorithms at American Society of Hematology Annual Meeting | PR Newswire | 12/3/2019

… Chief Executive Officer and Chief Medical Officer stated, “Cancer is complex disease and requires complex biomarkers for predicting its behavior. RNA Sequencing provides a wealth of information that can be used for predicting clinical course … Marrow: The Role for Complementary Peripheral Blood and Bone Marrow Genomic Analysis” Collaborators: Departments of Leukemia, Genomic, and Hematopathology, UT MD Anderson Cancer Center, Houston, TX. About Genomic Testing Cooperative, LCA Genomic Testing Cooperative (GTC …

Medical Research

Mary-Claire King, PhD, Joins the New York Genome Center as Senior Associate Core Member | PR Newswire | 11/25/2019

… schizophrenia, contributing to the understanding of complex disease inheritance. In 2014, Dr. King received the Lasker Special Achievement Award for Medical Research and in 2016, the United States National Medal of Science. Dr. King is … disease, and cancer. Leveraging our strengths in whole genome sequencing, genomic analysis, and development of new genomic tools, the NYGC serves as a nexus for collaboration in disease-focused genomic research for the New York …

National Cancer Institute

Mary-Claire King, PhD, Joins the New York Genome Center as Senior Associate Core Member | PR Newswire | 11/25/2019

… on numerous government panels and with private organizations, including the National Academy of Sciences, the National Institutes of Health, the National Cancer Institute, and the Robert Wood Johnson Foundation. She also has served on the … disease, and cancer. Leveraging our strengths in whole genome sequencing, genomic analysis, and development of new genomic tools, the NYGC serves as a nexus for collaboration in disease-focused genomic research for the New York …

Population Health

LifeOmic Partners with AdventHealth to Power Population Health Studies in Florida | PR Newswire | 10/16/2019

… creators of the LIFE mobile apps and the Precision Health Cloud, today announced a partnership with AdventHealth to power two population health initiatives for Florida residents. LifeOmic’s Precision Health Cloud is being used in the … surveys. Once results are received, researchers are able to conduct genomic analysis in the PHC alongside integrated medical records. “Initiatives like the Lake Nona Life and WholeMe projects give Florida residents the opportunity to make …

Clinical Data

Genomenon’s Mastermind to be Integrated into SOPHiA Platform and Alamut Suite | PRWeb | 10/15/2019

… the Alamut Suite . The partnership puts the most up-to-date genomic research at the fingertips of clinical researchers performing genomic analysis worldwide. The SOPHiA Platform is the technology of choice for streamlined Data-Driven … helping healthcare professionals make sense of the large amount of clinical data. SOPHiA GENETICS is democratizing Data-Driven Medicine by enabling the rapid adoption of genomic and radiomic analysis worldwide, turning data into actionable insights …

Clinical Diagnostics

Promega Hosts Fight Colorectal Cancer (Fight CRC) Research Advocacy Training and Support (RATS) Program | Business Wire | 10/11/2019

… the unique opportunity to engage in lab activities with Promega scientists while learning about topics such as: molecular oncology workflow genomic analysis for cancer bioluminescence and drug discovery immunotherapy and hereditary cancer risk microsatellite instability … their particular experiences as well,” says Heather Tomlinson, Director of Clinical Diagnostics at Promega “We are especially eager to share our insight of the role inherited genetic conditions such as Lynch syndrome plays in increasing …

ACO

The Cerrado once connected the Andes with the Atlantic Rainforest | Phys Org | 4/18/2019

… Andes and Brazil’s Atlantic Rainforest biome are separated by almost 1,000 km of drier areas with open vegetation in the Chaco, Cerrado (Brazilian savanna), and Caatinga (Brazilian semiarid) biomes. Today, these tropical forests are not … They then used DNA sequences from 71 birds and the genomic analysis of samples from other 33 specimens to evaluate the genetic structure of the population and the gene flow within the species. Lastly, they …

Patient Registry

Goldfinch Bio Announces Collaborations With Icahn School Of Medicine At Mount Sinai And Vanderbilt University Medical Center To Augment World’s Largest Genomic Registry Of Patients With Kidney Disease - TheStreet | 10/17/2017

… genomic analysis and de-identified clinical data from Mount Sinai’s BioMe BioBank and Vanderbilt’s BioVU BioBank to expand Goldfinch’s Patient Registry, generating an unparalleled collection of insights from patients with kidney disease. Goldfinch Bio is leading a new age of therapeutic discovery and development in the kidney space, and is building the world’s largest genomic registry of patients with kidney disease to inform new disease targets, pathways, and biomarkers for …

Thermo Fisher

COVID-19: Genomics Market (2020-2024)- Roadmap for Recovery | Demand for Creating and Upgrading Genome Databases to Boost the Market Growth | Technavio | Business Wire | 9/11/2020

… global market during the forecast period. What are the major trends in the market? Growing adoption of single cell-based genomic analysis is one of the major trends in the market. At what rate is … General Electric Co., Illumina Inc., PerkinElmer Inc., QIAGEN NV, and Thermo Fisher Scientific Inc. are some of the major market participants. What are the key market drivers? Demand for creating and upgrading genome databases is …

Key Players in The $852 Million Genomics Market At Investing in New Product Launches | PR Newswire | 4/13/2020

… DNA Electronics Ltd, Enumeral, Epic Sciences, Kellbenx Inc., Resolution Bio Science Inc., Wafergen Bio-systems Inc., Yikon Genomics Co. Ltd, Thermo Fisher Scientific Inc., CellBio, Beckman Coulter , Becton Dickinson , Bio-Rad, Carl Zeiss Microscopy, Cell … also segmented by process into cell isolation, sample preparation, and genomic analysis. By end user it is segmented into academic institutes, biopharmaceutical companies, and clinical research institutes. Here Is A List Of Similar Reports By …

Thermo Fisher Scientific

COVID-19: Genomics Market (2020-2024)- Roadmap for Recovery | Demand for Creating and Upgrading Genome Databases to Boost the Market Growth | Technavio | Business Wire | 9/11/2020

… global market during the forecast period. What are the major trends in the market? Growing adoption of single cell-based genomic analysis is one of the major trends in the market. At what rate is … General Electric Co., Illumina Inc., PerkinElmer Inc., QIAGEN NV, and Thermo Fisher Scientific Inc. are some of the major market participants. What are the key market drivers? Demand for creating and upgrading genome databases is …

Key Players in The $852 Million Genomics Market At Investing in New Product Launches | PR Newswire | 4/13/2020

… DNA Electronics Ltd, Enumeral, Epic Sciences, Kellbenx Inc., Resolution Bio Science Inc., Wafergen Bio-systems Inc., Yikon Genomics Co. Ltd, Thermo Fisher Scientific Inc., CellBio, Beckman Coulter , Becton Dickinson , Bio-Rad, Carl Zeiss Microscopy, Cell … also segmented by process into cell isolation, sample preparation, and genomic analysis. By end user it is segmented into academic institutes, biopharmaceutical companies, and clinical research institutes. Here Is A List Of Similar Reports By …

Illumina

COVID-19: Genomics Market (2020-2024)- Roadmap for Recovery | Demand for Creating and Upgrading Genome Databases to Boost the Market Growth | Technavio | Business Wire | 9/11/2020

genomic analysis is one of the major trends in the market. At what rate is the market projected to grow? Growing at a CAGR of almost 13%, the incremental growth of the market is anticipated to be USD 17.23 billion. Who are the top players in the market? Agilent Technologies Inc., BGI Genomics Co. Ltd., Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., General Electric Co., Illumina

Illumina Acquires BlueBee to Accelerate Processing, Analysis and Sharing of Next Generation Sequencing Data at Scale | Business Wire | 6/18/2020

SAN DIEGO- Illumina, Inc. (NASDAQ: ILMN) is enhancing its capabilities to analyze and interpret the data produced by its sequencing systems with the acquisition of BlueBee, a cloud-based software company that provides genomics analysis … Illumina software products provides the most scalable, efficient and extensible genomic analysis solutions for both clinical and translational research use cases. BlueBee truly brings unique capabilities, while ensuring secure deployment of clinical informatics across the …

Qiagen

Key Players in The $852 Million Genomics Market At Investing in New Product Launches | PR Newswire | 4/13/2020

… and aims to advance the field of CAR-T therapy. Some key players in the genomics market include 10X Genomics, Qiagen NV, Fluidigm Corporation, Johnson & Johnson Private Limited, Zephyrus Biosciences Inc., Illumina, Inc., Affymetrix, Angle … also segmented by process into cell isolation, sample preparation, and genomic analysis. By end user it is segmented into academic institutes, biopharmaceutical companies, and clinical research institutes. Here Is A List Of Similar Reports By …

The dynamics of the inflammatory response during BBN-induced bladder carcinogenesis in mice | 11/28/2019

… on alkylating DNA damage and the accumulation of mutations that lead to muscle-invasive bladder cancer (MIBC) in mice [ 13 ]. Genomic analysis of BBN-induced cancer in mice revealed a genomic mutational landscape similar to … array, and next-generation sequencing RNA was extracted using QIAzol (Qiagen) from bladder tissue according to the manufacturer’s instruction. In the final step, RNA was dissolved in water. One microgram of total RNA was used …

Merck

Myriad Seeks Japanese Regulatory Approval for its BRACAnalysis® Diagnostic System in People with Advanced Pancreatic and Prostate Cancer | Globe Newswire | 3/30/2020

Merck & Co., Inc. in the United States and Canada). About SRL Since the establishment in 1970, SRL, Inc., a member of the Miraca Group, Japan-based leading healthcare group, has been providing comprehensive testing services as the largest commercial clinical laboratory in Japan. SRL carries out nearly 400,000,000 tests per year, covering a wide range of testing services including general/emergency testing, esoteric/research testing, companion diagnostics tests, genomic analysis

TEPMETKO® (Tepotinib) Approved in Japan for Advanced NSCLC with METex14 Skipping Alterations | PR Newswire | 3/25/2020

… Mar 25, 2020, 03:00 ET Share this article ROCKLAND, Mass. , March 25, 2020 /PRNewswire/ – EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, today announced that the Japanese Ministry … for the detection of MET gene alterations. ArcherDX is a genomic analysis company dedicated to democratizing precision oncology through a suite of products and services that are accurate, personal, actionable and easy to use in …

Quest Diagnostics

Global Oral Fluid Collection Devices Market Growth 2019-2024 | 10/28/2019

… Collection Devices Consumption CAGR by Region 2.2 Oral Fluid Collection Devices Segment by Type 2.2.1 General Analysis Collection Devices 2.2.2 Genomic Analysis Collection Devices 2.3 Oral Fluid Collection Devices Consumption by Type 2.3.1 Global Oral … Business Overview 12.6.2 Oral Fluid Collection Devices Product Offered 12.6.3 Quest Diagnostics Oral Fluid Collection Devices Sales, Revenue, Price and Gross Margin (2017-2019) 12.6.4 Main Business Overview 12.7.2 Oral Fluid Collection Devices Product Offered 12.7.3 …

Hereditary Cancer Testing Markets, 2019-2027 - Growing Demand for Non-invasive Methods of Detection Presents Opportunities | Globe Newswire | 10/16/2019

… with the patient. They support groups and other information resources and provide emotional support to the person getting the results. Genomic analysis is used to monitor, diagnose, treat, forecast, and prevent diseases, and promote good … SWOT Analysis 12.1.6 Key Developments 12.2 Koninklijke Philips N.V. 12.3 Quest Diagnostics Incorporated 12.4 Myriad Genetics Inc. 12.5 Cancer Genetics Inc. 12.6 Invitae Corporation 12.7 Myogenes 12.8 Strand Life Sciences Pvt. Ltd. 12.9 Pathway Genomics …

Varian

Genomenon Partners with Google to Make Genomic Data Available on Google Cloud Platform | PRWeb | 4/16/2019

… Inc. announced a partnership with Google to make the company’s genomic mutation data available on Google Cloud Platform. Genomenon’s Cited Variants Reference (CVR) data will be a public dataset available in BigQuery, Google Cloud’s big … be used as an evidence filter for clinical actionability in genomic analysis pipelines (based on the presence of evidence in the literature) and a quick way to get insight into the literature for variant curation …

Parabricks Brings Accelerated and AI-Based Genomic Analysis to Google Cloud Platform Marketplace | PR Newswire | 4/16/2019

… product suite for primary and secondary analysis of sequencing data. Now available on the Google Cloud Platform (GCP) Marketplace, Parabricks reduces the time and cost required to go from raw sequencing data to variants for a whole genome, producing variant calls in less than an hour compared to the standard 30 hours when running the same industry standard pipeline on HPC CPU clusters. The Parabricks enterprise-grade analysis suite provides …

HLM Venture Partners

DermTech Announces Successful Closing of Business Combination with Constellation Alpha Capital Corp. | BioSpace | 9/3/2019

… exceeding the $15 million closing cash requirement previously announced. Participating investors included experienced life sciences investors such as RTW Investments, HLM Venture Partners, Irwin and Gary Jacobs, the founding family of Qualcomm, Inc., and two … PLA), enables non-invasive and early detection of melanoma using genomic analysis. Studies to date have shown that the PLA test enhances the early detection of melanoma with a higher diagnostic performance than biopsy, the …

Iris Dorbian wrote a new post, Constellation and DermTech merge, on the site PE Hub | 8/30/2019

By Iris Dorbian Constellation Alpha Capital Corp , a blank check company and DermTech , a provider of genomic analysis of skin samples, have completed their previously announced merger. Participating investors included RTW Investments, HLM Venture Partners, Irwin and Gary Jacobs and the founding family of Qualcomm Inc . Cowen and Company LLC served as financial and capital markets adviser on the transaction. The newly combined company will be trading August 30, 2019 …

Third Rock Ventures

ArcherDX Announces the Appointment of Steven J. Kafka, Ph.D. as Executive Chairman of the Board of Directors | PR Newswire | 5/29/2019

… this expanded capacity,” said Jason Myers , co-founder and Chief Executive Officer of ArcherDX. Dr. Kafka is a Partner at Third Rock Ventures, a leading healthcare venture capital firm that invests in disruptive areas of … Jason and his team deliver best in class NGS-based genomic analysis to cancer researchers and patients around the world,” said Steve Kafka . “ArcherDX’s AMP technology is the best platform to power the democratization of …

Goldfinch Bio Announces Collaborations With Icahn School Of Medicine At Mount Sinai And Vanderbilt University Medical Center To Augment World’s Largest Genomic Registry Of Patients With Kidney Disease - TheStreet | 10/17/2017

… Vanderbilt University Medical Center to generate genomic data on over 1,500 patients with proteinuric kidney disease. The collaborations will integrate genomic analysis and de-identified clinical data from Mount Sinai’s BioMe BioBank and Vanderbilt’s BioVU … people with kidney disease. Goldfinch was launched in 2016 by Third Rock Ventures, and is headquartered in Cambridge, Mass. For more information, please visit www.goldfinchbio.com . Goldfinch Bio Contact Jennifer Williams Cook Williams Communications, Inc. jennifer …

Moffitt Cancer Center

Researchers complete largest genomic analysis of Merkel cell carcinoma patients | 8/20/2019

Merkel cell carcinoma (MCC) is a rare, aggressive skin tumor that is diagnosed in approximately 2,000 people each year in the United States. Since MCC affects so few people, it is difficult to study the genetic factors that lead to its development and how those factors correlate with response to therapy. However, Moffitt Cancer Center researchers have developed the largest descriptive genomic analysis of MCC patients to date, in collaboration …

Largest genomic analysis could help improve treatment for Merkel cell carcinoma patients | 8/20/2019

Moffitt Cancer Center researchers have developed the largest descriptive genomic analysis of MCC patients to date, in collaboration with Foundation Medicine and the Dana Farber Cancer Institute. Their analysis, published in Clinical Cancer Research, will provide important information to improve the care and treatment of MCC patients for many years to come. Researchers are beginning to learn more about how MCC develops and its associated risk factors. Many patients with …

Vanderbilt University Medical Center

Goldfinch Bio Announces Collaborations With Icahn School Of Medicine At Mount Sinai And Vanderbilt University Medical Center To Augment World’s Largest Genomic Registry Of Patients With Kidney Disease - TheStreet | 10/17/2017

CAMBRIDGE, Mass. , Oct. 17, 2017 /PRNewswire/ – Goldfinch Bio, a company singularly focused on discovering and developing precision therapies to treat patients with kidney disease, today announced collaborations with the Icahn School of Medicine at Mount Sinai and Vanderbilt University Medical Center to generate genomic data on over 1,500 patients with proteinuric kidney disease. The collaborations will integrate genomic analysis and de-identified clinical data from Mount Sinai’s BioMe BioBank and …

Goldfinch Bio Announces Collaborations with Icahn School of Medicine at Mount Sinai and Vanderbilt University Medical Center to Augment World’s Largest Genomic Registry of Patients with Kidney Disease | PR Newswire | 10/17/2017

Goldfinch Bio Announces Collaborations with Icahn School of Medicine at Mount Sinai and Vanderbilt University Medical Center to Augment World’s Largest Genomic Registry of Patients with Kidney Disease News provided by 07:30 ET Share this … 1,500 patients with proteinuric kidney disease. The collaborations will integrate genomic analysis and de-identified clinical data from Mount Sinai’s BioMe BioBank and Vanderbilt’s BioVU BioBank to expand Goldfinch’s Patient Registry, generating an unparalleled collection …

John Dobak

DermTech Announces Inclusion in the Russell 2000 Index | Business & Finance | manchestertimes.com | Business Wire | 6/30/2020

… our inclusion in the Russell 2000 ® Index, one of the most widely cited performance benchmarks for small-cap companies,” said John Dobak, M.D., Chief Executive Officer of DermTech. “This is an important milestone for DermTech … leading to improved patient care and lower costs. DermTech provides genomic analysis of skin samples collected non-invasively using an adhesive patch rather than a scalpel. DermTech markets and develops products that facilitate the early …

DermTech Announces Response to COVID-19 | Business Wire | 3/25/2020

… leader in precision dermatology enabled by a non-invasive skin genomics platform, today released the following letter from its CEO John Dobak, M.D.: We at DermTech are monitoring the COVID-19 pandemic daily. In these … leading to improved patient care and lower costs. DermTech provides genomic analysis of skin samples collected non-invasively using an adhesive patch rather than a scalpel. DermTech markets and develops products that facilitate the early …

Jason Myers

ArcherDX Enters Collaboration with Bristol Myers Squibb to Apply Personalized Cancer Monitoring (PCM™) to Clinical Research | PR Newswire | 6/18/2020

… precision oncology into early-stage cancers, when the cancer is typically easier to cure compared to late-stage cancers,” said Jason Myers , Chief Executive Officer and co-founder of ArcherDX. “This collaboration further underscores our … and outside the U.S. About ArcherDX ArcherDX is a leading genomic analysis company democratizing precision oncology through a suite of products and services that are highly accurate, personal, actionable and easy to use in local …

ArcherDX Receives Approval for Archer®MET Companion Diagnostic for TEPMETKO® (Tepotinib) in Advanced Non-Small Cell Lung Cancer in Japan | PR Newswire | 3/25/2020

… diagnostic for TEPMETKO means NSCLC patients will have access to Merck KGaA, Darmstadt, Germany’s targeted therapy with demonstrated efficacy,” said Jason Myers , Ph.D., Chief Executive Officer and co-founder, ArcherDX. “This approval is the most … use outside of Japan . About ArcherDX ArcherDX is a leading genomic analysis company democratizing precision oncology through a suite of products and services that are highly accurate, personal, actionable and easy to use in local …

Cambridge, Massachusetts

Congenica Completes $50m Series C Funding Round to - One News Page | 11/9/2020

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations Cambridge, United Kingdom ‚Äì 9 November 2020 - Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people‚Äôs lives, is pleased to announce the completion of its …

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform | 11/9/2020

Genomic Analysis Software and Data Platform Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations Cambridge, United Kingdom ‚Äì 9 November 2020 ‚Äì Congenica , the digital health …

New York, New York

COVID research updates: Teenager spreads coronavirus on family holiday | Nature | 10/6/2020

… antibodies against ‘seasonal’ coronaviruses can protect against severe COVID-19. Paul Bieniasz and Theodora Hatziioannou at the Rockefeller University in New York City and their colleagues analysed 37 blood-serum samples collected before 2020 from … to the coronavirus says about the prospects for a vaccine Genomic analysis by Jason Goldman at the University of Washington, Seattle, and his colleagues (J. D. Goldman et al . Preprint at medRxiv https://doi.org/fbvj …

How COVID-19 has opened science | 9/15/2020

genomic analysis of the first cases in Washington state, which concluded the virus had been spreading silently for weeks, primed public health and civic leaders for a speedy shutdown of major businesses and conventions in Seattle in the first week of March. That prompt response is credited by many for averting a catastrophic spread such as occurred only weeks later in New York City, where nearly 24,000 later died from …

State of New York

COVID research updates: Teenager spreads coronavirus on family holiday | Nature | 10/6/2020

… antibodies against ‘seasonal’ coronaviruses can protect against severe COVID-19. Paul Bieniasz and Theodora Hatziioannou at the Rockefeller University in New York City and their colleagues analysed 37 blood-serum samples collected before 2020 from … to the coronavirus says about the prospects for a vaccine Genomic analysis by Jason Goldman at the University of Washington, Seattle, and his colleagues (J. D. Goldman et al . Preprint at medRxiv https://doi.org/fbvj …

How COVID-19 has opened science | 9/15/2020

genomic analysis of the first cases in Washington state, which concluded the virus had been spreading silently for weeks, primed public health and civic leaders for a speedy shutdown of major businesses and conventions in Seattle in the first week of March. That prompt response is credited by many for averting a catastrophic spread such as occurred only weeks later in New York City, where nearly 24,000 later died from …

York, Pennsylvania

COVID research updates: Teenager spreads coronavirus on family holiday | Nature | 10/6/2020

… against ‘seasonal’ coronaviruses can protect against severe COVID-19. Paul Bieniasz and Theodora Hatziioannou at the Rockefeller University in New York City and their colleagues analysed 37 blood-serum samples collected before 2020 from people … to the coronavirus says about the prospects for a vaccine Genomic analysis by Jason Goldman at the University of Washington, Seattle, and his colleagues (J. D. Goldman et al . Preprint at medRxiv https://doi.org/fbvj …

How COVID-19 has opened science | 9/15/2020

genomic analysis of the first cases in Washington state, which concluded the virus had been spreading silently for weeks, primed public health and civic leaders for a speedy shutdown of major businesses and conventions in Seattle in the first week of March. That prompt response is credited by many for averting a catastrophic spread such as occurred only weeks later in New York City, where nearly 24,000 later died from …